Inhaled insulin to be introduced in Pakistan

[mnholdem]

Inhalable insulin for diabetics to be introduced in Pakistan
Sep.03,2018

KARACHI: After research by health experts, diabetes patients will now be able to use insulin inhalers instead of insulin injections – a more advanced treatment for diabetic patients which will be introduced soon.

This was announced at a seminar, ‘International Conference on Diabetes and Endocrinology’, jointly organised by the Express Media Group and Family Medicine in Karachi.

Source: www.google.com/amp/s/tribune.com.pk/story/1793679/1-inhalable-insulin-diabetics-introduced-pakistan-soon/%3Famp%3D1?source=images

[centralcoastinvestor]

Sept 3, 2018 13:56:58 GMT -5 mnholdem said:

Inhalable insulin for diabetics to be introduced in Pakistan
Sep.03,2018

KARACHI: After research by health experts, diabetes patients will now be able to use insulin inhalers instead of insulin injections – a more advanced treatment for diabetic patients which will be introduced soon.

This was announced at a seminar, ‘International Conference on Diabetes and Endocrinology’, jointly organised by the Express Media Group and Family Medicine in Karachi.

Source: www.google.com/amp/s/tribune.com.pk/story/1793679/1-inhalable-insulin-diabetics-introduced-pakistan-soon/%3Famp%3D1?source=images

They don’t mention Afrezza but that is the only inhaled insulin.  This is very good news.  Continuing expansion.  

[babaoriley]

CCI, if it is Afrezza, "this is very good news," would be a gross understatement! 

[peppy]

Pakistan was not shown to be targeted. Tanner?

[sportsrancho]

[sayhey24]

This is great news but this caught my attention in the article - "a more advanced treatment for diabetic patients which will be introduced soon".

Maybe that's the line Mike needs to start promoting as his marketing pitch - "a more advanced treatment for diabetic patients".

[mnholdem]

Even though these were recent articles (2 were published in September 2018) I dug a little deeper and learned that the International Diabetes and Endocrine Congress (IDEC) in Karachi, Pakistan was held August 19-22, 2016.

These articles do not mention being reprints but they do state the comments were made at that conference.

So, unfortunately, I now think this may be old news. My apologies if it is. Since that time, I think MannKind CEO mentioned, in effect, that he was scuttling deals with individual countries in preference to negotiating a deal with a regional player.

Cipla may be the exception to this because of the sheer size of the diabetes market in India.

[mnholdem]

Cipla does serve more countries than just India, though:

“Cipla has a wide presence internationally, covering South-East Asia, Middle-East, Latin America, Africa, Australia, New Zealand and Russia-CIS. The company offers a diverse range of more than 1000 products in over 100 countries.”

Source: www.cipla.com/en/our-businesses/geographies/international.html

[tw12]

"Afrezza, the inspired insulin."